AUBYN FRIEDLAND: Open Payments
NPI 1881318475 · BELLA VISTA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 55 payments from 17 companies in 2025. Trend: 2023 $1,077 · 2024 $811 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $203 |
| PFIZER INC. | 10 | $138 |
| Amgen Inc. | 6 | $91 |
| ABBVIE INC. | 5 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| Astellas Pharma US Inc | 4 | $70 |
| Phathom Pharmaceuticals, Inc. | 3 | $39 |
| Inspire Medical Systems, Inc. | 2 | $37 |
| Dexcom, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
Products named: Wegovy, Kerendia, Veozah, Ozempic, ELIQUIS, NURTEC ODT, OTEZLA, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
